Offer - Urjas Oil for just ₹ 1 X
Inditel AM 40 Tablet is a prescription drug, available for use as Tablet. Inditel AM 40 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Inditel AM 40 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Inditel AM 40 Tablet include Headache, Dizziness, Palpitations (fluttering in chest). Some other side effects of Inditel AM 40 Tablet have been listed ahead. Normally, these side effects of Inditel AM 40 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Inditel AM 40 Tablet's effect during pregnancy is Severe and Severe while nursing. It is important to know if Inditel AM 40 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Inditel AM 40 Tablet related warnings section.
Inditel AM 40 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Inditel AM 40 Tablet in conditions like Congestive Heart Failure (CHF), Coronary Artery Disease (CAD), Angioedema.
Additionally, Inditel AM 40 Tablet may also adversely react with other medicines. See below for a complete list.
You should also be aware that Inditel AM 40 Tablet is not safe while driving, and is not addiction.
Inditel AM 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Inditel AM 40 Tablet safe for pregnant women?
Inditel AM should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Inditel AM 40 Tablet safe during breastfeeding?
Inditel AM should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Inditel AM 40 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Inditel AM. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Inditel AM 40 Tablet on the Liver?
Inditel AM can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Inditel AM 40 Tablet on the Heart?
The heart can be affected by Inditel AM. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Inditel AM 40 Tablet unless your doctor advises you to do so -
Is this Inditel AM 40 Tablet habit forming or addictive?
Forming a habit of Inditel AM 40 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Inditel AM 40 Tablet as you may feel sleepy.
Is it safe?
Inditel AM 40 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Inditel AM 40 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Inditel AM 40 Tablet
Due to the absence of research, it is difficult to say how Inditel AM 40 Tablet and food will interact.
Interaction between Alcohol and Inditel AM 40 Tablet
It is difficult to say anything about the effect of Inditel AM 40 Tablet and alcohol. No research has been done on this yet.
No, Inditel AM is not bad for kidneys. In fact, it protects the kidneys, thus, it is suitable for people with diabetes and mild-to-moderate kidney disease.
No, Inditel AM is not a beta blocker/calcium channel blocker/diuretic/blood thinner/ace inhibitor. It is angiotensin II receptor blocker (an antihypertensive drug).
Yes, it is safe to take Inditel AM as long as it is prescribed by your doctor. However, in some people, it may cause some side effects like back pain, sinusitis, and diaarhea.
Inditel AM is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Inditel AM might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Inditel AM exactly as prescribed by their doctor.
Yes, Inditel AM may cause a cough on rare occasions. If you experience a cough while taking Inditel AM, please talk to your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148